Breakthrough Genomics is an advanced clinical lab based in Southern California that is a leader in the clinical interpretation of genomic data. The company provides a range of cutting-edge genetic tests and and lab services that help make precision medicine a reality.
By combining next generation computing power with the clinical expertise of a certified CAP/CLIA lab, Breakthrough Genomics genetic tests deliver high diagnostic yields with fast turnaround times.
Breakthrough Genomics’ ability to deliver “better results faster” for a wide-range of genetic tests is the result of the company’s proprietary techniques and a powerful in-house interpretation engine.
The company’s founders have over 65 years of hands-on experience in the field of clinical genomics and have directed programs for leading institutions including Ilumina, Quest Diagnostics, and Children’s Hospital Los Angeles.
The revolutionary methodology employed by the Breakthrough Genomics’ team leverages intelligent bio-informatic architecture that is able to simultaneously analyze millions of up-to-date scientific publications and terabytes of clinical genomic data.
Breakthrough Genomics works with healthcare providers, research institutions, and partner organizations both in the U.S. and overseas and provides a number of distinct genetic tests including:
- Rapid Whole Genome and Whole Exome
- Hereditary Cancer Screening
- Targeted Cardiovascular
- Rare Disease Diagnosis
Depending on the genetic test being analyzed, the Breakthrough Genomics team uses one of two proprietary AI-powered diagnostic platforms - ENLITER and VIRTUAL GENETICIST both designed to streamline the process of determining the correct diagnosis, even for the most difficult cases.
Brands: BETTER RESULTS. FASTER. This mantra is possible by leveraging the ENLITER and VIRTUAL GENETICIST platforms. The company’s PCR and Genetic Tests will soon be offered under the brand MYGENESCAN.